Johnson & Johnson (JNJ) EBIT (2009 - 2026)
Johnson & Johnson (JNJ) posted EBIT of $6.18 billion for Q3 2026, down 12.1% from $7.03 billion a year earlier and down 13.4% from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) EBIT (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 27, 2026, EBIT at Johnson & Johnson was $25.19 billion, up 7.4% year-over-year; for FY2025, it was $25.37 billion, up 20.7% from FY2024.
- Annual EBIT shows a four-year compound annual growth rate of 6.6% (FY2021 to FY2025).
- In prior years, Johnson & Johnson's EBIT was $21.02 billion in FY2024 (-2.3%), $21.52 billion in FY2023 (+3.8%), $20.74 billion in FY2022 and $19.67 billion in FY2021.
- Quarterly EBIT has run from a low of $3.6 billion in Q4 2024 to a high of $7.14 billion in Q2 2026 over five years.
- On a year-over-year basis, EBIT increased in six of the last eight quarters, with growth averaging 10.4%.
- The strongest year-over-year quarter for EBIT in the past five years was Q4 2025, with growth of 53.0%; the weakest was Q4 2023, with a decline of 38.1%.
- According to Business Quant data, EBIT for the three prior quarters was $7.14 billion (Q2 2026), $6.36 billion (Q1 2026) and $5.51 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Vertex Pharmaceuticals | 132.74 Bn | 104.74 Bn | 2.84 Bn | 1.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 6.18 Bn |
| Jun 28, 2026 | 7.14 Bn |
| Mar 29, 2026 | 6.36 Bn |
| Dec 28, 2025 | 5.51 Bn |
| Sep 28, 2025 | 7.03 Bn |
| Jun 29, 2025 | 6.65 Bn |
| Mar 30, 2025 | 6.18 Bn |
| Dec 29, 2024 | 3.60 Bn |
| Sep 29, 2024 | 5.04 Bn |
| Jun 30, 2024 | 6.47 Bn |
| Mar 31, 2024 | 5.91 Bn |
| Dec 31, 2023 | 4.25 Bn |
| Oct 1, 2023 | 5.74 Bn |
| Jul 2, 2023 | 5.81 Bn |
| Apr 2, 2023 | 5.72 Bn |
| Jan 1, 2023 | 6.87 Bn |
| Oct 2, 2022 | 5.30 Bn |
| Jul 3, 2022 | 3.88 Bn |
| Apr 3, 2022 | 4.35 Bn |
| Oct 3, 2021 | 6.61 Bn |
API Access
Johnson & Johnson EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();